1895-1955 · Physician and investigator of radioiodine therapy for metastatic thyroid carcinoma
Samuel M. Seidlin
Montefiore Hospital, New York
According to a 1999 memoir, Seidlin gave radioiodine in 1943 to a patient with metastases of thyroid adenocarcinoma, recognised that some metastases take up radioiodine only after the normal thyroid is removed, and with his group followed many patients with metastatic thyroid carcinoma from 1942 until his death. First author, with Marinelli and Oshry, of a 1946 JAMA report on radioiodine therapy of functioning metastases of thyroid adenocarcinoma.
Milestones
Sources
Siegel E. The beginnings of radioiodine therapy of metastatic thyroid carcinoma: a memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient. Cancer Biother Radiopharm. 1999;14(2):71-9.
SEIDLIN SM, MARINELLI LD, OSHRY E. Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. J Am Med Assoc. 1946;132(14):838-47.
Norman JM. HistoryofMedicine.com (Garrison-Morton-Norman bibliography, archived earlier version), entry 11520: Marinelli LD, Oshry E, Seidlin SM. Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid. J Am Med Assoc 132:838-847, 1946. Page read 20 October 2026.